Literature DB >> 26773734

Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.

Akito Dobashi1, Naoko Tsuyama2, Reimi Asaka1,2, Yuki Togashi1,2, Kyoko Ueda3, Seiji Sakata1, Satoko Baba1, Kana Sakamoto1, Kiyohiko Hatake3, Kengo Takeuchi1,2.   

Abstract

Extranodal natural killer/T cell lymphoma (ENKTL) is a rare subtype of lymphoma. Recurrent mutations in the JAK-STAT pathway, recently reported in ENKTL cases, are interesting in terms of both pathogenesis and inhibitor therapy. However, the frequencies of these mutations are low and variable among reports, and other pathognomonic mutations in ENKTL remain to be elucidated. In the present study, targeted capture sequencing of 602 cancer-related genes from 25 frozen ENKTL samples was performed, 11 of which were matched to normal samples. Several recurrent somatic mutations involving BCOR (32%), TP53 (16%), DDX3X (12%), FAT4 (8%), NRAS (8%), MLL3 (12%), and MIR17HG (8%) were identified. The pattern of BCOR aberrations (1 nonsense and 5 frame-shift mutations, a mutation leading to a splicing error, and gene loss) suggested that loss of function of BCOR was the functionally important outcome of such changes. The literature was reviewed and the public data on BCOR aberrations was reanalyzed and it was found that the aberrations were frequently found in myeloid neoplasms, but, interestingly, were highly specific to ENKTL among lymphoid malignancies. Given the high frequency and pattern of aberration, BCOR is likely to play an important role in ENKTL pathogenesis as a tumor suppressor gene.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26773734     DOI: 10.1002/gcc.22348

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  43 in total

1.  Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.

Authors:  Lien N Hoang; Amandeep Aneja; Niamh Conlon; Deborah F Delair; Sumit Middha; Ryma Benayed; Martee L Hensley; Kay J Park; Travis J Hollmann; Meera R Hameed; Cristina R Antonescu; Robert A Soslow; Sarah Chiang
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

2.  BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation.

Authors:  Joanna K Lempiäinen; A B M Kaiser Manjur; Marjo Malinen; Kirsi Ketola; Einari A Niskanen; Jorma J Palvimo
Journal:  Oncogene       Date:  2020-01-10       Impact factor: 9.867

3.  Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia.

Authors:  Liang Huang; Dan Liu; Na Wang; Shaoping Ling; Yuting Tang; Jun Wu; Lingtong Hao; Hui Luo; Xuelian Hu; Lingshuang Sheng; Lijun Zhu; Di Wang; Yi Luo; Zhen Shang; Min Xiao; Xia Mao; Kuangguo Zhou; Lihua Cao; Lili Dong; Xinchang Zheng; Pinpin Sui; Jianlin He; Shanlan Mo; Jin Yan; Qilin Ao; Lugui Qiu; Hongsheng Zhou; Qifa Liu; Hongyu Zhang; Jianyong Li; Jie Jin; Li Fu; Weili Zhao; Jieping Chen; Xin Du; Guoliang Qing; Hudan Liu; Xin Liu; Gang Huang; Ding Ma; Jianfeng Zhou; Qian-Fei Wang
Journal:  Cell Res       Date:  2017-11-17       Impact factor: 25.617

4.  KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.

Authors:  Yusuke Isshiki; Yaeko Nakajima-Takagi; Motohiko Oshima; Kazumasa Aoyama; Mohamed Rizk; Shuhei Kurosawa; Atsunori Saraya; Takashi Kondo; Emiko Sakaida; Chiaki Nakaseko; Koutaro Yokote; Haruhiko Koseki; Atsushi Iwama
Journal:  Blood Adv       Date:  2019-09-10

5.  Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma.

Authors:  Haijun Wen; Huajuan Ma; Qichun Cai; Suxia Lin; Xinxing Lei; Bin He; Sijin Wu; Zifeng Wang; Yan Gao; Wensheng Liu; Weiping Liu; Qian Tao; Zijie Long; Min Yan; Dali Li; Keith W Kelley; Yongliang Yang; Huiqiang Huang; Quentin Liu
Journal:  Nat Med       Date:  2018-01-01       Impact factor: 53.440

6.  Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.

Authors:  Tammy Linlin Song; Maarja-Liisa Nairismägi; Yurike Laurensia; Jing-Quan Lim; Jing Tan; Zhi-Mei Li; Wan-Lu Pang; Atish Kizhakeyil; Giovani-Claresta Wijaya; Da-Chuan Huang; Sanjanaa Nagarajan; Burton Kuan-Hui Chia; Daryl Cheah; Yan-Hui Liu; Fen Zhang; Hui-Lan Rao; Tiffany Tang; Esther Kam-Yin Wong; Jin-Xin Bei; Jabed Iqbal; Nicholas-Francis Grigoropoulos; Siok-Bian Ng; Wee-Joo Chng; Bin-Tean Teh; Soo-Yong Tan; Navin Kumar Verma; Hao Fan; Soon-Thye Lim; Choon-Kiat Ong
Journal:  Blood       Date:  2018-07-27       Impact factor: 22.113

7.  Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders.

Authors:  Li-Min Gao; Sha Zhao; Wen-Yan Zhang; Mi Wang; Hui-Fang Li; Anle Lizaso; Wei-Ping Liu
Journal:  Cancer Biol Ther       Date:  2019-07-16       Impact factor: 4.742

Review 8.  Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders.

Authors:  Geoffrey Shouse; Liana Nikolaenko
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

9.  A Case Series of BCOR Sarcomas With a New Splice Variant of BCOR/CCNB3 Fusion Gene.

Authors:  Anastasios Kyriazoglou; Natalia Tourkantoni; Michalis Liontos; Flora Zagouri; Louisa Mahaira; Alexandra Papakosta; Dimitra Michali; Amalia Patereli; Kalliopi Stefanaki; Vasiliki Tzotzola; Evangelia Skoura; Margarita Baka; Sofia Polychronopoulou; Antonis Kattamis; Efthymios Dimitriadis
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

10.  ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.

Authors:  Natasha Lewis; Robert A Soslow; Deborah F Delair; Kay J Park; Rajmohan Murali; Travis J Hollmann; Ben Davidson; Francesca Micci; Ioannis Panagopoulos; Lien N Hoang; Javier A Arias-Stella; Esther Oliva; Robert H Young; Martee L Hensley; Mario M Leitao; Meera Hameed; Ryma Benayed; Marc Ladanyi; Denise Frosina; Achim A Jungbluth; Cristina R Antonescu; Sarah Chiang
Journal:  Mod Pathol       Date:  2017-12-01       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.